Stereotactic Biopsy Split-Course Radiation Therapy in Diffuse Midline Glioma, SPORT-DMG Study

PHASE2RecruitingINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

October 11, 2021

Primary Completion Date

October 15, 2027

Study Completion Date

October 15, 2027

Conditions
Diffuse Midline Glioma, H3 K27M-Mutant
Interventions
RADIATION

Hypofractionated Radiation Therapy

Undergo hypofractionated radiation therapy

OTHER

Questionnaire Administration

Ancillary studies

PROCEDURE

Magnetic Resonance Imaging

Undergo MRI

PROCEDURE

Positron Emission Tomography and Computed Tomography Scan

Undergo PET-CT scan

Trial Locations (2)

55905

RECRUITING

Mayo Clinic in Rochester, Rochester

85054

RECRUITING

Mayo Clinic Hospital in Arizona, Phoenix

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT05077735 - Stereotactic Biopsy Split-Course Radiation Therapy in Diffuse Midline Glioma, SPORT-DMG Study | Biotech Hunter | Biotech Hunter